Home › Funds › First Eagle Investment Management › BIO

First Eagle Investment Management position in BIO

BIO RAD LABS INC · Industrials

First Eagle Investment Management reported holding 2,455,580 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$927.5M, representing 1.46% of its reported portfolio and ranking #25 among its reported holdings. First Eagle Investment Management has disclosed BIO holdings in 14 of the last 14 reported quarters, going back to Q2 2023.

Latest position (Q3 2026)2.46M sh
Reported value held$927.50M
Portfolio Weight1.46%
First reportedQ2 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How First Eagle Investment Management's BIO position evolved

First Eagle Investment Management first disclosed a stake in BIO in Q2 2023 at 191 shares (US$72K). The position peaked in Q3 2026 at 2,455,580 shares, worth US$927.5M. Across 14 filings, First Eagle Investment Management increased the stake 9 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 2,455,580 shares valued at US$927.5M — a reduction of -150,639 shares quarter over quarter.. Notable position changes include a 140% increase in Q3 2023 (shares fell 10% over the following quarter), a 310% increase in Q1 2024 (shares fell 21% over the following quarter), a 32297% increase in Q2 2024 (shares rose 23% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2023 191 $72.41K New
Q3 2023 458 $164.17K Add
Q4 2023 479 $154.66K Add
Q1 2024 1.96K $679.29K Add
Q2 2024 636.27K $173.77M Add
Q3 2024 713.00K $238.56M Add
Q4 2024 713.50K $234.39M Hold
Q1 2025 1.57M $381.46M Add
Q2 2025 2.52M $607.48M Add
Q3 2025 2.52M $706.67M Hold
Q4 2025 2.57M $778.83M Add
Q1 2026 2.60M $725.52M Add
Q2 2026 2.61M $765.21M Hold
Q3 2026 2.46M $927.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC) is a Industrials company. 24 other funds we track also report a position in BIO — the largest reported positions include ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M), First Pacific Advisors, LP (US$101.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has First Eagle Investment Management held BIO?

First Eagle Investment Management has disclosed BIO holdings in 14 of the last 14 reported quarters, going back to Q2 2023.

What is First Eagle Investment Management's current position in BIO?

As of Q3 2026, First Eagle Investment Management holds 2.46M shares of BIO (BIO RAD LABS INC), valued at $927.50M, representing 1.46% of its reported portfolio and ranking #25.

Has First Eagle Investment Management been buying or selling BIO?

In the latest 13F filing (Q3 2026), First Eagle Investment Management reduced its position in BIO. The position peaked in Q3 2026 at 2.46M shares.

Which other funds hold BIO?

Other major institutional holders of BIO include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, First Pacific Advisors, LP, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.